Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengzhilin Li

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 23, 2025
Inflammasome mediated in situ cancer vaccine activated by schottky heterojunction for augmented immunotherapyChengzhilin Li, Nianlei Zhang, Ziang Xu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 22, 2024
CD169+ Macrophages Mediate the Immune Response of Allergic Rhinitis Through the Keap1/Nrf2/HO-1 AxisWenwen Qi, Chengcheng Liu, Lei Shi, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 23, 2025
Inflammasome mediated in situ cancer vaccine activated by schottky heterojunction for augmented immunotherapyChengzhilin Li, Nianlei Zhang, Ziang Xu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 22, 2024
CD169+ Macrophages Mediate the Immune Response of Allergic Rhinitis Through the Keap1/Nrf2/HO-1 AxisWenwen Qi, Chengcheng Liu, Lei Shi, et al.
Pageof 2